Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levcromakalim provocation in cluster headache
NCT05093582Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jun 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Levcromakalim with Placebo (2 arms). Primary endpoint: Occurrence of cluster headache attacks at 90 minutes. Started Jun 2021; status: completed.
02
Drugs
levcromakalim
Beyond the preview
Go deeper on NCT05093582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05093582.